Panalgo and HealthEconomics.Com hosted a webinar detailing strategies that lead to successful evaluation by the Institute for Clinical and Economic Review (ICER). President of HealthEconomics.Com Patti Peeples moderated the session, which included important insights from Center for the Evaluation of […]
MMIT and Evaluate Acquire Panalgo to Streamline RWE and Ultimately Improve Patient Outcomes
Managed Markets Insight & Technology (MMIT) and Evaluate announced their acquisition of healthcare analytics company Panalgo. This acquisition will streamline real world evidence (RWE) studies and shorten the drug development pipeline, leading to faster and more effective therapies […]
Whitepaper on Tailoring Your Novel Therapeutic to ICER Standards
ICER (the Institute for Clinical and Economic Review) is an independent nonprofit organization dedicated to the fair evaluation of prescription drugs and other therapeutics, including medical devices. In its evaluations, it takes into account not only a drug’s efficacy, but also its cost relative to […]
Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics
Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data. EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) […]
